BridgeMD
New treatment option for Stroke
Official title Playing Piano to Improve Hand Function Early After Stroke
ClinicalTrials.gov ID: NCT06621771
What this study is testing
- What it's testing
- The goal of this clinical trial is to study the feasibility of a 6-week piano playing training intervention in a subacute stroke population. More specifically, the investigators aim to (1) implement and test the feasibility of the intervention in the subacute stroke rehabilitation program; and (2) explore the acceptability of the supervised training sessions and home practice sessions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 74
You may be able to join if
- Have normal/corrected visual and auditory acuity
- Present a first-ever supratentorial unilateral stroke (1-24 weeks post-stroke)
- Present some capacity of dissociation of arm and finger movements, as reflected by scores of 3 to 6 on the arm and hand components of the Chedoke...
- Have the capacity to follow simple instructions
- Have no professional piano experience (only for the piano group)
You likely can't join if
- Presence of visual field defect, hemineglect as well as dementia or moderate-to-severe cognitive deficits (score less than 18 on the Montreal...
The study team makes the final eligibility decision.
Where it's taking place
- Laval, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Laval, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.